$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000143774921018788 Filed on August 05, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$8.653M	$40.35M	$2.620M
YoY Change	-78.55%	932.47%	-74.95%
Cost Of Revenue	$996.0K	$4.797M	$109.1K
YoY Change	-79.24%		-88.08%
Gross Profit	$7.657M	$35.55M	$2.511M
YoY Change	-78.46%	809.72%	-73.69%
Gross Profit Margin	88.49%	88.11%	95.84%
Selling, General & Admin	$5.392M	$3.871M	$3.176M
YoY Change	39.3%	14.11%	0.3%
% of Gross Profit	70.42%	10.89%	126.5%
Research & Development	$2.264M	$2.710M	$3.150M
YoY Change	-16.45%	32.94%	-21.19%
% of Gross Profit	29.57%	7.62%	125.47%
Depreciation & Amortization	$134.8K	$140.0K	$133.2K
YoY Change	-3.69%	9.75%	-3.31%
% of Gross Profit	1.76%	0.39%	5.3%
Operating Expenses	$7.656M	$6.581M	$6.326M
YoY Change	16.34%	17.24%	-23.48%
Operating Profit	$1.102K	$28.80M	-$3.998M
YoY Change	-100.0%	-1788.73%	-282.4%
Interest Expense	$0.00	$0.00	$3.017M
YoY Change		-100.0%	-23.21%
% of Operating Profit	0.0%	0.0%
Other Income/Expense, Net	$24.24K	$31.93K	$412.4K
YoY Change	-24.1%	-95.67%	-43.98%
Pretax Income	$467.6K	$27.21M	-$11.60M
YoY Change	-98.28%	-735.41%	-643.09%
Income Tax	$300.0K	$6.300M	-$2.700M
% Of Pretax Income	64.16%	23.15%
Net Earnings	$169.2K	$20.89M	-$8.898M
YoY Change	-99.19%	-760.56%	-645.94%
Net Earnings / Revenue	1.96%	51.77%	-339.63%
Basic Earnings Per Share	$0.00	$0.26	-$0.11
Diluted Earnings Per Share	$0.00	$0.26	-$0.11
COMMON SHARES
Basic Shares Outstanding	75.81M	80.34M	81.24M
Diluted Shares Outstanding	76.66M	80.52M	81.24M

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.49M	$53.10M	$77.40M
YoY Change	85.47%	-47.06%	-24.19%
Cash & Equivalents	$98.49M	$53.07M	$77.38M
Short-Term Investments
Other Short-Term Assets	$1.774M	$1.400M	$2.600M
YoY Change	26.73%	-90.48%	-83.12%
Inventory	$19.60M	$14.01M	$16.34M
Prepaid Expenses
Receivables	$7.206M	$36.61M	$1.686M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$127.1M	$105.1M	$98.02M
YoY Change	20.94%	-13.55%	-20.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.597M	$2.366M	$2.501M
YoY Change	9.77%	-17.26%	-16.29%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$392.7K	$901.9K	$848.0K
YoY Change	-56.46%	-3.02%	-14.6%
Total Long-Term Assets	$6.620M	$15.35M	$20.55M
YoY Change	-56.87%	-81.18%	-75.21%
TOTAL ASSETS
Total Short-Term Assets	$127.1M	$105.1M	$98.02M
Total Long-Term Assets	$6.620M	$15.35M	$20.55M
Total Assets	$133.7M	$120.4M	$118.6M
YoY Change	11.02%	-40.71%	-42.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$675.4K	$630.2K	$4.766M
YoY Change	7.18%	-41.16%	121.71%
Accrued Expenses	$7.295M	$14.93M	$16.66M
YoY Change	-51.14%	48.54%	67.29%
Deferred Revenue	$3.655M	$10.63M	$13.60M
YoY Change	-65.62%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$7.970M	$15.56M	$21.42M
YoY Change	-48.78%	39.9%	76.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$8.995M	$10.70M	$9.000M
YoY Change	-15.94%	0.0%	-22.41%
Total Long-Term Liabilities	$8.995M	$10.70M	$9.000M
YoY Change	-15.94%	-87.91%	-89.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.970M	$15.56M	$21.42M
Total Long-Term Liabilities	$8.995M	$10.70M	$9.000M
Total Liabilities	$16.97M	$26.28M	$30.43M
YoY Change	-35.45%	-73.62%	-69.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$109.0M	-$127.3M	-$132.9M
YoY Change	-14.37%	8.47%	16.43%
Common Stock	$225.7M	$221.4M	$221.1M
YoY Change	1.94%	0.28%	0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$116.7M	$94.13M	$88.14M
YoY Change
Total Liabilities & Shareholders Equity	$133.7M	$120.4M	$118.6M
YoY Change	11.02%	-40.71%	-42.56%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	$169.2K	$20.89M	-$8.898M
YoY Change	-99.19%	-760.56%	-645.94%
Depreciation, Depletion And Amortization	$134.8K	$140.0K	$133.2K
YoY Change	-3.69%	9.75%	-3.31%
Cash From Operating Activities	-$1.427M	-$9.090M	$3.322M
YoY Change	-84.31%	108.97%	35324.32%
INVESTING ACTIVITIES
Capital Expenditures	-$14.42K	$0.00	-$20.00K
YoY Change			100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$14.42K	$0.00	-$15.50K
YoY Change			73.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$993.4K
YoY Change
Debt Paid & Issued, Net			$85.91M
YoY Change
Cash From Financing Activities	-6.603M	-15.22M	-$86.92M
YoY Change	-56.61%		153490.0%
NET CHANGE
Cash From Operating Activities	-1.427M	-9.090M	$3.322M
Cash From Investing Activities	-14.42K	0.000	-$15.50K
Cash From Financing Activities	-6.603M	-15.22M	-$86.92M
Net Change In Cash	-8.044M	-24.31M	-$83.61M
YoY Change	-66.91%	458.85%	148772.25%
FREE CASH FLOW
Cash From Operating Activities	-$1.427M	-$9.090M	$3.322M
Capital Expenditures	-$14.42K	$0.00	-$20.00K
Free Cash Flow	-$1.412M	-$9.090M	$3.342M
YoY Change	-84.46%	108.97%	17147.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75389417
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75076665
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75389417
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77195704
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77195704
	siga	Inventory Writedown Net Of Credits InventoryWritedownNetOfCredits	600000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	900000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98486013	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117890240	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7206135	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3340263	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	19599891	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	20265519	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1774218	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	143608091	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2597296	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2103990	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2731473	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2544053	USD
CY2021Q2	us-gaap	Goodwill Goodwill	898334	USD
CY2020Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	392665	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	676923	USD
CY2021Q2	us-gaap	Assets Assets	133686025	USD
CY2020Q4	us-gaap	Assets Assets	149831391	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	675403	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2112069	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	127066257	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1278217	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7295055	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9205293	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7970458	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10483510	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5278141	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6639211	USD
CY2021Q2	us-gaap	Other Liabilities OtherLiabilities	3716464	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	2915401	USD
CY2021Q2	us-gaap	Liabilities Liabilities	16965063	USD
CY2020Q4	us-gaap	Liabilities Liabilities	20038122	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	7539	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7720	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225678876	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	224978430	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108965453	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-95192881	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	116720962	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	129793269	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	133686025	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149831391	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8653289	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40348777	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13467033	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42968542	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	995990	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4796768	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1246838	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4905863	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5216059	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3870927	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9272243	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7046952	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2263971	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2709743	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4566756	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5859847	USD
CY2021Q2	siga	Patent Preparation Fees PatentPreparationFees	176167	USD
CY2020Q2	siga	Patent Preparation Fees PatentPreparationFees	174203	USD
	siga	Patent Preparation Fees PatentPreparationFees	369501	USD
	siga	Patent Preparation Fees PatentPreparationFees	356800	USD
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	8652187	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	11551641	USD
	us-gaap	Costs And Expenses CostsAndExpenses	15455338	USD
	us-gaap	Costs And Expenses CostsAndExpenses	18169462	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1102	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	28797136	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1988305	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	24799080	USD
CY2021Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-442269	USD
CY2020Q2	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1619587	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-1361070	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1635652	USD
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	-0	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	-0	USD
	us-gaap	Interest Expense InterestExpense	-0	USD
	us-gaap	Interest Expense InterestExpense	3016817	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	24235	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31931	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49803	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	444295	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	467606	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27209480	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-577432	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15609445	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298406	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6319322	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65473	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3616816	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	169200	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
	us-gaap	Net Income Loss NetIncomeLoss	-642905	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75810641
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80340695
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76281211
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80790400
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76660054
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80516863
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77128973
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80959812
	us-gaap	Net Income Loss NetIncomeLoss	-642905	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264834	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	267669	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-1361070	USD
	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	1635652	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	713817	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	582549	USD
	siga	Inventory Writedown Net Of Credits InventoryWritedownNetOfCredits	630707	USD
	siga	Inventory Writedown Net Of Credits InventoryWritedownNetOfCredits	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-187420	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2967402	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4981461	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	887132	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3865872	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	-0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	85913459	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13143219	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102139375	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19404227	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-107921101	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32443665	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34921	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1751459	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-622109	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1203690	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2819298	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4421690	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	373593	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8332405	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6236584	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5766225	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	24424	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	15501	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24424	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15501	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13361	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9746	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13129858	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16216170	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117890240	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160986934	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98486013	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53065833	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	68000000.0	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	6100000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3678647	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2944932	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6961400	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6274944	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4364104	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4170954	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2597296	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2103990	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000	USD
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14908	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2628153	USD
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	17844691	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15415425	USD
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1740292	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2221941	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	19599891	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	20265519	USD
CY2021Q2	siga	Inventory Writedown Net Of Credits InventoryWritedownNetOfCredits	600000	USD
CY2021Q2	us-gaap	Inventory Write Down InventoryWriteDown	900000	USD
CY2020Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	405176	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	278788	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	486158	USD
CY2021Q2	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	144973	USD
CY2020Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	327606	USD
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	27407	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	919555	USD
CY2021Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	20670	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	150349	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7295055	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9205293	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3654540	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3280947	USD
CY2021Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1672113	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2933738	USD
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	630506	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	251824	USD
CY2021Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	432621	USD
CY2021Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5300000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6639211	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1361070	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5278141	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	169200	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
	us-gaap	Net Income Loss NetIncomeLoss	-642905	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	428128	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1346929	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-258928	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	20890158	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1989834	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	11992629	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75810641
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80340695
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76281211
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80790400
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	849413
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	176168
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	847762
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	169412
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76660054
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80516863
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77128973
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80959812
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2021Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	15400000	USD
CY2021Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	500000	USD
CY2020Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	27200000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6300000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-600000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	15600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3600000	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.638	pure
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021Q2	siga	Effective Income Tax Rate Reconciliation Expiration Of Stock Options Amount EffectiveIncomeTaxRateReconciliationExpirationOfStockOptionsAmount	200000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.113	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	siga	Effective Income Tax Rate Reconciliation Expiration Of Stock Options Amount EffectiveIncomeTaxRateReconciliationExpirationOfStockOptionsAmount	200000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	122684867	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	169200	USD
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6600510	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	467405	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	116720962	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	129793269	USD
	us-gaap	Net Income Loss NetIncomeLoss	-642905	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13129858	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13361	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	713817	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	116720962	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	88142122	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	20890158	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15222795	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	323533	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	94133018	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	97783756	USD
	us-gaap	Net Income Loss NetIncomeLoss	11992629	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	16216170	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9746	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	582549	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	94133018	USD
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
CY2021Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000000.0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1900000
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6600000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13100000	USD
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	USD
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	251289	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	627731	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	669048	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	678627	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	406994	USD
CY2021Q2	siga	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	575887	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3209576	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	373593	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2835983	USD

Files In Submission

Name	View Source	Status
0001437749-21-018788-index-headers.html	Edgar Link	pending
0001437749-21-018788-index.html	Edgar Link	pending
0001437749-21-018788.txt	Edgar Link	pending
0001437749-21-018788-xbrl.zip	Edgar Link	pending
ex_248047.htm	Edgar Link	pending
ex_248048.htm	Edgar Link	pending
ex_248049.htm	Edgar Link	pending
ex_248050.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20210630.xsd	Edgar Link	pending
siga-20210630_cal.xml	Edgar Link	unprocessable
siga-20210630_def.xml	Edgar Link	unprocessable
siga-20210630_lab.xml	Edgar Link	unprocessable
siga-20210630_pre.xml	Edgar Link	unprocessable
siga20210630_10q.htm	Edgar Link	pending
siga20210630_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2021 Q2 Form 10-Q Financial Statement

#000143774921018788 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2021 Q2 Form 10-Q Financial Statement

#000143774921018788 Filed on August 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga